Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use
I'm PortAI, I can summarize articles.
Tilray Brands Inc ( NASDAQ:TLRY ) shares are trading higher on Wednesday after a Marijuana Moment report cited findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions. Here's what investors need to know.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments